NCT05098834

Brief Summary

Children with acute respiratory failure often need a breathing tube attached to a breathing machine, called a mechanical ventilator, to assist their breathing until they can recover. Once the cause of respiratory failure has resolved or improved enough, the breathing tube can be removed, and that is called extubation. The Extubation Readiness Test (ERT) is a simple evaluation commonly performed in the intensive care unit to determine if a child is ready to have the breathing tube removed. The purpose of this study is to better understand how the ERT and the eventual removal of the breathing tube affect where the air is in the lungs, and whether this can help predict which children will succeed or fail having the breathing tube taken out. This can done be at the bedside with a device called electrical impedance tomograph. This novel device is painless and uses a belt fitted with sensors placed around the chest to show where the air is in the lungs.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Aug 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 18, 2021

Completed
10 days until next milestone

First Posted

Study publicly available on registry

October 28, 2021

Completed
2.8 years until next milestone

Study Start

First participant enrolled

August 1, 2024

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2025

Completed
Last Updated

September 19, 2024

Status Verified

June 1, 2024

Enrollment Period

5 months

First QC Date

October 18, 2021

Last Update Submit

September 6, 2024

Conditions

Keywords

Acute respiratory failureBreathing tubeMechanical ventilator

Outcome Measures

Primary Outcomes (1)

  • Change in expiratory lung volume as measured by global lung electrical impedance

    Baseline, 60 mins, 75 mins, 90 mins

Secondary Outcomes (3)

  • Change in regional ventilation (Anterior/Posterior) distribution as measured by regional electrical impedance

    Baseline, 60 mins, 75 mins, 90 mins

  • Change in regional ventilation (Right/Left) distribution as measured by regional electrical impedance

    Baseline, 60 mins, 75 mins, 90 mins

  • Percent of failed extubation as measured by need for re-intubation

    Within 24 hours

Study Arms (1)

PICU and PCICU Patients

EXPERIMENTAL

Patients younger than 17 years of age receiving mechanical ventilation for an acute respiratory illness will be approached to participate prior to initiation of an ERT for clinical purposes.

Device: ENLIGHT 2100 ventilatory electrical impedance tomograph

Interventions

The ENLIGHT 2100 system will remain connected to the patient for data acquisition from immediately prior to initiation of the ERT until up to 24 hours following extubation.

PICU and PCICU Patients

Eligibility Criteria

AgeUp to 17 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Patients less than 17 years of age admitted to the Duke Children's PICU or PCICU with acute respiratory failure due to a pulmonary illness will be considered eligible for the study

You may not qualify if:

  • Patients with corrected gestational age less than 37 weeks
  • Patients with contraindications to the ENLIGHT device (i.e. temporary or permanent pacemaker, vagal nerve stimulator, automatic implanted defibrillator, chest tubes that interfere with electrode belt placement, open chest wounds, unstable thorax, severe chest wall deformities)
  • known pregnancy
  • Patients previously enrolled in this study will be excluded from participation.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Duke University

Durham, North Carolina, 27705, United States

Location

Study Officials

  • Alexandre Rotta, MD, FCCM

    Duke University

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 18, 2021

First Posted

October 28, 2021

Study Start

August 1, 2024

Primary Completion

January 1, 2025

Study Completion

January 1, 2025

Last Updated

September 19, 2024

Record last verified: 2024-06

Data Sharing

IPD Sharing
Will not share

Locations